Testing effectiveness (Phase 2)Active Not RecruitingNCT01142388
What this trial is testing
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Who this might be right for
Metastatic Esophageal AdenocarcinomaMetastatic Esophageal Squamous Cell CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+5 more
National Cancer Institute (NCI) 94